Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-062092
Filing Date
2025-06-24
Accepted
2025-06-24 16:05:12
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518715-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2518715-1_4seq1.xml 4 18408
  Complete submission text file 0001104659-25-062092.txt   21780
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-531-9088
ADAR1 Partners, LP (Reporting) CIK: 0001758866 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251068974

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address
Schneeberger Daniel (Reporting) CIK: 0001861120 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251068972

Mailing Address 325 RANCH ROAD 620 SOUTH SUITE 200 AUSTIN TX 78738
Business Address 325 RANCH ROAD 620 SOUTH SUITE 200 AUSTIN TX 78738 512-531-9088
ADAR1 Capital Management GP, LLC (Reporting) CIK: 0001940267 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251068973

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Reporting) CIK: 0001940272 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251068975